association of serotonin transporter gene polymorphism 5httvntr with osteoporosis

Acta Reumatologica Portuguesa

Volumn 36, Issue 1, 2011, Pages 14-19

  Ferreira, Joana T ^a   Levy, Pilar Q ^a   Marinho, Claudia R ^a   Bicho, Manuel P ^a,d   Mascarenhas, Mário Rui G ^a,b,c  

^a Lisbon Medical School   (Portugal)

^b University Clinic of Endocrinology   (Portugal)

^c Endocrinology Department   (Portugal)

^d INSTITUTO DE INVESTIGAÇÃO CIENTÍFICA BENTO DA ROCHA CABRAL   (Portugal)

Author keywords

Bone Remodeling; Osteoporosis; Serotonin Transporter Polymorphisms.

Indexed keywords

SEROTONIN TRANSPORTER;

ARTICLE; FEMALE; GENETIC POLYMORPHISM; GENETICS; HUMAN; MALE; MIDDLE AGED; OSTEOPOROSIS;

FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; POLYMORPHISM, GENETIC; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 79955659140     PISSN: 0303464X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Warden SJ, Bliziotes MM, Wiren KM, Eshleman AJ and Turner CH. Neural regulation of bone and the skeletal effects of serotonin (5-hydroxytryptamine). Mol Cell Endocrinol 2005; 242: 1-9.
2. Ducy P, Amling M, Takeda S, Prieme M, et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 2000; 100: 197-207.
3. Baldock PA, Sainsbury A, Couzens M, et al. Hypothalamic Y2 receptors regulate bone formation. J Clin Invest 2002; 109: 915-921.
4. Gu Y and Publicover S.J. Expression of functional metabotropic glutamate receptors in primary cultured rat osteoblasts. Cross-talk with N-methyl-d-aspartate receptors. J Biol Chem 2000; 275: 34252--34259.
5. Kroeze WK, Kristiansen K, Roth BL. Molecular biology of serotonin receptors structure and function at the molecular level. Curr Top Med Chem 2002; 2: 507-528.
6. Talley NJ. Serotoninergic neuroenteric modulators. Lancet 2001; 358: 2061-2068.
7. Battaglino R, Fu J, Spate U, Ersoy U, Joe M, Sedaghat L, Stashenko P. Serotonin regulates osteoclast differentiation through its transporter. J Bone Miner Res 2004; 19: 1420-1431.
8. Bliziotes MM, Eshleman AJ, Zhang XW, Wiren K.M. Neurotransmitter action in osteoblasts: expression of a functional system for serotonin receptor activation and reuptake. Bone 2001; 29: 477-486.
9. Warden SJ, Robling AG, Sanders MS, Bliziotes MM, Turner C.H. Inhibition of the serotonin (5-hydroxytryptamine) transporter reduces bone accrual during growth. Endocrinology 2005; 146: 685-693.
10. WBodarski K, Włodarski P. Leptin as a modulator of osteogenesis. Ortop Traumatol Rehabil 2009;11:1-6.
11. Watts SW. 5-HT in systemic hypertension: foe, friend or fantasy? Clin Sci (Lond) 2005; 108: 399-412.
12. Lesch KP, Balling U, Gross J, et al. Organization of the human serotonin transporter gene. J Neural Transm Gen Sect 1994; 95: 157-162.
13. Heils A, Teufel A, Petri S, et al. Allelic variation of human serotonin transporter gene expression. J Neurochem 1996; 66: 2621-2624.
14. MacKenzie A, Quinn J. A serotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo. Proc Natl Acad Sci USA 1999; 96: 15251-15255.
15. Weintrob N, Cohen D, Klipper-Aurbach Y, Zadik Z, Dickerman Z. Decreased growth during therapy with selective serotonin reuptake inhibitors. Arch Pediatr Adolesc Med 2002; 156: 696-701.
16. Lahiri DK, Nurnberger JI, Jr. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 1991;19:5444.
17. Leibowitz SF and Alexander JT. Hypothalamic serotonin in control of eating behavior, meal size, and body weight. Biological Psychiatry 1998; 44: 851-864.